1. Home
  2. RYTM vs M Comparison

RYTM vs M Comparison

Compare RYTM & M Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rhythm Pharmaceuticals Inc.

RYTM

Rhythm Pharmaceuticals Inc.

HOLD

Current Price

$115.63

Market Cap

5.8B

Sector

Health Care

ML Signal

HOLD

Logo Macy's Inc

M

Macy's Inc

HOLD

Current Price

$25.40

Market Cap

6.5B

ML Signal

HOLD

Company Overview

Basic Information
Metric
RYTM
M
Founded
2008
1830
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Department/Specialty Retail Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
6.5B
IPO Year
2017
2003

Fundamental Metrics

Financial Performance
Metric
RYTM
M
Price
$115.63
$25.40
Analyst Decision
Strong Buy
Hold
Analyst Count
14
13
Target Price
$131.14
$20.09
AVG Volume (30 Days)
640.7K
4.6M
Earning Date
05-05-2026
05-27-2026
Dividend Yield
N/A
3.97%
EPS Growth
28.34
12.08
EPS
N/A
0.23
Revenue
N/A
$22,621,000,000.00
Revenue This Year
$55.34
N/A
Revenue Next Year
$86.06
N/A
P/E Ratio
N/A
$109.26
Revenue Growth
N/A
N/A
52 Week Low
$74.50
$12.02
52 Week High
$122.20
$26.59

Technical Indicators

Market Signals
Indicator
RYTM
M
Relative Strength Index (RSI) 60.52 56.27
Support Level $98.76 $22.32
Resistance Level $113.03 $25.87
Average True Range (ATR) 4.84 0.85
MACD 0.15 0.11
Stochastic Oscillator 98.64 61.03

Price Performance

Historical Comparison
RYTM
M

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. In addition, it has two early-stage investigational MC4R agonists in clinical development, RM-718 and bivamelagon, designed not to cause hyperpigmentation. The company is also focused on advancing potential candidates for congenital hyperinsulinism. It currently operates in two business segments: the United States, which generates maximum revenue, and International.

About M Macy's Inc

Founded in 1858 and based in New York City, Macy's operates about 430 eponymous stores, 60 stores under the Bloomingdale's (full-price and outlet) and Bloomie's names, and 170 freestanding Bluemercury specialty beauty stores. Macy's also operates e-commerce sites and licenses Bloomingdale's stores in the United Arab Emirates and Kuwait. Women's apparel, accessories, shoes, cosmetics, and fragrances constituted 64% of 2025 net retail sales.

Share on Social Networks: